Generic drug maker Watson Pharmaceuticals has entered a settlement that will allow it to launch a generic patch used to treat post herpetic neuralgia, a pain disorder associated with shingles.
Two drug makers are looking to win approval for an experimental drug in patients with colorectal cancer that has spread to other parts of the body.
The Food and Drug Administration has approved a new treatment for acne made by a GlaxoSmithKline subsidiary.
Pfizer has partnered with EatingWell magazine to launch the drug maker's Lipitor For You "Recipes 2 Go" mobile application.
The U.S. subsidiary of British drug maker GlaxoSmithKline and U.S.-based Auxilium Pharmaceuticals will co-promote a testosterone-replacement drug, the two said Monday.
Generic drug maker Dr. Reddy's Labs has launched a generic version of a drug used to prevent clotting of the blood.
The Food and Drug Administration has approved a treatment for Parkinson's disease made by Actavis, the drug maker said Friday.
Generic drug maker Watson Pharmaceuticals is challenging the patent protection of a contraceptive drug made by Warner Chilcott, Watson said Friday.
The Food and Drug Administration has approved generic versions of one of the country's top-selling drugs made by eight different companies, the agency said Thursday.
Sagent Pharmaceuticals has launched a generic version of a chemotherapy drug, the company said Thursday.
Amneal Pharmaceuticals is adding blackberry flavoring to a generic diabetes drug following feedback from customers, the company said Wednesday.
Watson has announced its intention to acquire Actavis, the company said. Following news reports that the U.S.-based generic drug maker would acquire Switzerland-based Actavis, Watson announced that it would buy the latter for $5.6 billion.
GlaxoSmithKline is acquiring the remainder of a privately owned research and development company, GSK said Tuesday.
Net revenues for Teva rose more than 24% for the first quarter ended March 31, thanks to new drug launches and the company's acquisition of drug maker Cephalon.
Pfizer apparently is relenting on its attempt to drive sales of its top cholesterol drug as several new generic versions look set to enter the market, according to published reports.
Biotech drug maker Amgen has joined the list of companies offering testimony at a Food and Drug Administration hearing on biosimilars Friday.
A Food and Drug Administration expert panel has recommended approval for a drug made by Pfizer for treating rheumatoid arthritis.
Generic drug maker Watson Pharmaceuticals has formed a special office to handle its pending acquisition of Actavis, the company said.
Generic drug maker Watson Pharmaceuticals is hoping to be the first to market a generic version of a drug used to treat ulcerative colitis, the company said.
A generic version of a schizophrenia drug made by Otsuka Holdings and Bristol-Myers Squibb can't be launched until April 2015, according to published reports.
Drug maker Purdue Pharma has introduced a new educational resource for healthcare professionals designed to curb the abuse of prescription drugs, the company said Monday.
Novartis' generics division has acquired Fougera Pharmaceuticals, the company said Wednesday.
Mylan plans to start selling a generic version of a drug for sleep disorders starting in June 2016, under a deal with Teva announced Monday.
Two companies have settled with Teva over the latter's efforts to launch a generic version of an emergency treatment for allergic reactions.
The Food and Drug Administration declined to approve a drug made by Takeda Pharmaceutical, the drug maker said.